Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 22Vitamin D Deficiency 3Osteoporosis 2Obesity 2Carcinoma, Intraductal, Noninfiltrating 2Triple Negative Breast Neoplasms 1Pathologic Processes 1Pain 1Osteoporosis Secondary 1Neuralgia 1Neoplasms by Site 1Neoplasms 1Musculoskeletal Diseases 1Locally Advanced Breast Cancer and Large Operable Breast Cancer 1Hyperplasia 1Breast Diseases 1Breast Carcinoma In Situ 1Biomarker Change Linked to Breast Cancer 1Arthralgia 1

Interventions

Fulvestrant 4ribociclib 3palbociclib 3abemaciclib 3Anastrozole 3selpercatinib 2exemestane 2Trastuzumab 2Letrozole 2Gonadotropin-Releasing Hormone 2Docetaxel 2AZD9833 2tucatinib 1ipatasertib 1glutathione pegylated liposomal doxorubicin 1entinostat 1elacestrant 1atezolizumab 1alectinib 1Zoledronic Acid 1Watchful Waiting 1Trabectedin 1Tamoxifen 1Sodium Chloride 1STX-478 1RAD1901 1Paclitaxel 1Metformin 1Imlunestrant 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms by Site × Cholecalciferol × Breast × Clear all
NCT01166763 2016-07-18

Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

University of Kansas Medical Center

Phase NA Completed
30 enrolled 10 charts
Breast

Breast Diseases, Breast Neoplasms, Hyperplasia, Neoplasms, Neoplasms by Site, Pathologic Processes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡